AI Article Synopsis

Article Abstract

Nuclear intermediate filament proteins, called lamins, form a meshwork that lines the inner surface of the nuclear envelope. Lamins contain three domains: an N-terminal head, a central rod and a C-terminal tail domain possessing an Ig-fold structural motif. Lamins are classified as either A- or B-type based on structure and expression pattern. The Drosophila genome possesses two genes encoding lamins, Lamin C and lamin Dm(0), which have been designated A- and B-type, respectively, based on their expression profile and structural features. In humans, mutations in the gene encoding A-type lamins are associated with a spectrum of predominantly tissue-specific diseases known as laminopathies. Linking the disease phenotypes to cellular functions of lamins has been a major challenge. Drosophila is being used as a model system to identify the roles of lamins in development. Towards this end, we performed a comparative study of Drosophila and human A-type lamins. Analysis of transgenic flies showed that human lamins localize predictably within the Drosophila nucleus. Consistent with this finding, yeast two-hybrid data demonstrated conservation of partner-protein interactions. Drosophila lacking A-type lamin show nuclear envelope defects similar to those observed with human laminopathies. Expression of mutant forms of the A-type Drosophila lamin modeled after human disease-causing amino acid substitutions revealed an essential role for the N-terminal head and the Ig-fold in larval muscle tissue. This tissue-restricted sensitivity suggests a conserved role for lamins in muscle biology. In conclusion, we show that (1) localization of A-type lamins and protein-partner interactions are conserved between Drosophila and humans, (2) loss of the Drosophila A-type lamin causes nuclear defects and (3) muscle tissue is sensitive to the expression of mutant forms of A-type lamin modeled after those causing disease in humans. These studies provide new insights on the role of lamins in nuclear biology and support Drosophila as a model for studies of human laminopathies involving muscle dysfunction.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762312PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007564PLOS

Publication Analysis

Top Keywords

a-type lamins
16
lamins
13
a-type lamin
12
drosophila
10
comparative study
8
study drosophila
8
drosophila human
8
a-type
8
human a-type
8
lamins nuclear
8

Similar Publications

A growing body of evidence suggests that actin plays a role in nuclear architecture, genome organisation, and regulation. Our study of human lung adenocarcinoma cells demonstrates that the equilibrium between actin isoforms affects the composition of the nuclear lamina, which in turn influences nuclear stiffness and cellular behaviour. The downregulation of β-actin resulted in an increase in nuclear area, accompanied by a decrease in A-type lamins and an enhancement in lamin B2.

View Article and Find Full Text PDF
Article Synopsis
  • Hutchison-Gilford progeria syndrome (HGPS) is a genetic disorder caused by a mutation in the LMNA gene, leading to rapid aging and serious health issues, including bone density loss and a shorter life span.
  • In studies using Lmna progeria mice, researchers analyzed bone mineralization and found similarities in mineral content across various ages but noted a higher number of empty osteocyte lacunae, indicating bone deterioration.
  • The findings highlighted significant reductions in bone volume and abnormal growth plates in Lmna mice, suggesting that bone dysplasia occurs due to problems in bone formation despite normal turnover rates.
View Article and Find Full Text PDF

Hutchinson-Gilford progeria syndrome (HGPS) is a progeroid disorder characterized by multiple aging-like phenotypes, including disease in large arteries. HGPS is caused by an internally truncated prelamin A (progerin) that cannot undergo the ZMPSTE24-mediated processing step that converts farnesyl-prelamin A to mature lamin A; consequently, progerin retains a carboxyl-terminal farnesyl lipid anchor. In cultured cells, progerin and full-length farnesyl-prelamin A (produced in cells) form an abnormal nuclear lamin meshwork accompanied by nuclear membrane ruptures and cell death; however, these proteins differ in their capacity to cause arterial disease.

View Article and Find Full Text PDF

Perinuclear assembly of vimentin intermediate filaments induces cancer cell nuclear dysmorphia.

J Biol Chem

December 2024

Institute of Biochemistry and Molecular Biology, National Yang Ming Chiao Tung University, Taipei, Taiwan; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan. Electronic address:

Article Synopsis
  • - Nuclear dysmorphia, which refers to abnormal nuclear shapes in cancer cells, is linked to cancer severity and is characterized by irregular nuclear formations, with vimentin being a key protein involved in this process.
  • - In breast cancer cells (MDA-MB-231), vimentin intermediate filaments were found to accumulate at the concave areas of dysmorphic nuclei, and removing vimentin helped restore the nuclear shape, unlike a mutant form that couldn't assemble correctly.
  • - The study also revealed that depleting vimentin in lung cancer cells (A549) reduced nuclear dysmorphia during a process induced by TGFβ and associated with further DNA repair defects, indicating vimentin's
View Article and Find Full Text PDF
Article Synopsis
  • Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder caused by a mutation in the LMNA gene, leading to accelerated aging and severe cardiovascular issues starting within the first year of life.
  • The study found that progerin expression in vascular smooth muscle cells (VSMCs) causes increased cell death, which is linked to elevated levels of poly(ADP-Ribosyl)ation and reduced nicotinamide adenine dinucleotide (NAD) levels.
  • A new compound, trifluridine, was discovered to increase NAD levels by reducing PARP-1 activity, and its treatment showed potential in reducing VSMCs loss and improving clinical signs of progeria in mice
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!